Psoriasis and psoriatic arthritis (PsA) are chronic immune-mediated diseases that can create substantial long-term healthcare burden. For policymakers, the strongest […]
Takeda’s narcolepsy strategy goes beyond drug development. The company is working with academic sleep researchers, clinical centers, medical experts and
Not every CDMO that can manufacture sterile injectables is equipped to handle complex sterile formulations. Standard injectables may involve relatively
Theranostics combines molecular imaging with targeted treatment, allowing clinicians to identify suitable patients and then treat the same biological target.
The U.S. EHR landscape is highly concentrated. Epic, Oracle Health and MEDITECH remain the biggest hospital-focused vendors, while TruBridge, Altera
Large-scale pharmaceutical, healthcare, food, personal-care and industrial manufacturing depends on reliable suppliers of solvents, polymers, intermediates, excipients, surfactants and specialty
GLP-1 drugs have become one of the biggest growth engines in pharmaceuticals, moving from a diabetes-focused treatment category into a
Oncology has remained one of the most important investment areas in healthcare, attracting venture capital firms, corporate investors and pharmaceutical
For a biotech or pharmaceutical company preparing a first-in-human (FIH) study with an oral solid dosage (OSD), the CDMO needs
Applied Behavior Analysis (ABA) practices increasingly depend on specialized software to manage clinical documentation, scheduling, data collection, billing, authorizations, payroll